Mitochondrial pyruvate carrier 1 expression controls cancer epithelial‐mesenchymal transition and radioresistance. Issue 4 (4th April 2019)

• Record Type: Journal Article
• Authors: Takaoka, Yuji; Konno, Masamitsu; Koseki, Jun; Colvin, Hugh; Asai, Ayumu; Tamari, Keisuke; Satoh, Taroh; Mori, Masaki; Doki, Yuichiro; Ogawa, Kazuhiko; Ishii, Hideshi
• Is Part Of: Cancer science. Volume 110:Issue 4(2019)
• Page Start: 1331
• Page End: 1339
• Publication Date: 2019-04-04
• Subjects: EMT -- glutamine -- metabolism -- mitochondria pyruvate career -- radiation therapy; Cancer -- Periodicals; Neoplasms -- Periodicals; Research -- Periodicals; Electronic journals; 616.994005
• DOI: 10.1111/cas.13980
• Languages: English
• ISSNs: 1347-9032

Abstract

Abstract : Mitochondrial pyruvate carrier (MPC) is known to cause different expressions in normal and cancer cells. We observed a change in phenotype with the suppression of MPC expression. We knocked down MPC1 and/or MPC2 using siRNA or shRNA. We observed its cell morphology and accompanying molecular marker. Furthermore, the radioresistance of the MPC knockdown cell line was examined using a colony formation assay. MPC1‐suppressed cells changed their morphology to a spindle shape. Epithelial‐mesenchymal transition (EMT) was suspected, and examination of the EMT marker by PCR showed a decrease in E‐cadherin and an increase in fibronectin. Focusing on glutamine metabolism as the mechanism of this phenomenon, we knocked down the glutamine‐metabolizing enzyme glutaminase (GLS). EMT was also observed in GLS‐suppressed cells. Furthermore, when MPC1‐suppressed cells were cultured in a glutamine‐deficient medium, changes in EMT markers were suppressed. In addition, MPC1‐suppressed cells also increased with a significant difference in radioresistance. Decreased MPC1 expression favorably affects EMT and radioresistance of cancer. Abstract : Function of low MPC expression in EMT and radioresistance.